Immunoglobulin Igg4 (230-proline)
Immunoglobulin Igg4 (230-proline) Uses, Dosage, Side Effects, Food Interaction and all others data.
Immunoglobulin Igg4 (230-proline) is under investigation in clinical trial NCT03546907 (Proof-of-concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-il-33 Mab) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)).
| Trade Name | Immunoglobulin Igg4 (230-proline) |
| Generic | Itepekimab |
| Itepekimab Other Names | Immunoglobulin igg4 (230-proline), anti-(human interleukin 33) (human monoclonal regn3500 .gamma.4-chain), disulfide with human monoclonal regn3500 .kappa.-chain, dimer, Itepekimab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Immunoglobulin Igg4 (230-proline)
